Ann: First Patient Treated in Landmark Alzheimer's Clinical Trial, page-38

The share price at the moment isnt a concern. We weren't tradeing these volumes before phase 2 so my gess is its someone tradeing there own parcels to push the price down. What i do like is they havent started the entire trial at the one time, they've broken it up into different time frames so they can assess the trial at different stages and pull it up if needed which would save them a lot of money. They have said the first patients are being dosed here in australia so by October they will have a good idea if it has any merit. We may not find out but its my bet the large pharmaceutical will. Watch for movement in the share price one way or the other around then it will give us an idea whats happening. Oh and by the way im not worried about averaging up or down im just buying what i can aford at these prices when possible.